Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | -0.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | -0.34% | |||
| Cost of Revenue | -2.75% | 130.70% | |||
| Gross Profit | -2.75% | -22.75% | |||
| SG&A Expenses | -2.75% | -10.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2.75% | 68.90% | |||
| Total Operating Expenses | -2.75% | 12.51% | |||
| Operating Income | 2.74% | -62.88% | |||
| Income Before Tax | 2.74% | -73.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.74% | -73.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.74% | -73.29% | |||
| EBIT | 2.74% | -62.88% | |||
| EBITDA | 2.75% | -193.66% | |||
| EPS Basic | 2.53% | -64.58% | |||
| Normalized Basic EPS | 2.04% | -63.33% | |||
| EPS Diluted | 2.53% | -64.58% | |||
| Normalized Diluted EPS | 2.04% | -63.33% | |||
| Average Basic Shares Outstanding | 0.00% | 5.48% | |||
| Average Diluted Shares Outstanding | 0.00% | 5.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||